Abacavir/Lamivudine Glenmark

Abacavir/Lamivudine Glenmark is a combination medication used in the treatment of HIV infection. This oral medication helps manage the virus and improve quality of life.

Abacavir/Lamivudine Glenmark is primarily used in the management of HIV infection. This combination therapy works by reducing the amount of HIV in the body, helping to slow the progression of the disease. It is often prescribed as part of a broader treatment plan to improve immune function and reduce the risk of complications associated with HIV.

Common effects of Abacavir/Lamivudine Glenmark may include headaches, nausea, and fatigue. Some individuals might experience skin rashes or changes in body fat distribution. These effects vary and are not experienced by everyone.

Abacavir/Lamivudine Glenmark should be handled with care. It is important to inform healthcare providers about any allergies or pre-existing conditions before starting this medication. Regular monitoring and follow-up are recommended to ensure safety and effectiveness.

Abacavir/Lamivudine Glenmark may interact with other medications, including certain antiviral drugs and immune modulators. Alcohol and other substances that affect liver function should be avoided. Always consult a healthcare provider before combining this medication with other treatments.